logo

Voyager Therapeutics (VYGR)



Trade VYGR now with
  Date
  Headline
11/20/2017 7:00:42 AM Wedbush Reiterates Voyager Therapeutics (VYGR) At Outperform With $22 Down From $26 Price Target
11/7/2017 11:05:27 PM Voyager Therapeutics Prices Public Offering Of 4.5 Mln Common Shares At $12/Shr
11/3/2017 2:28:09 PM Wedbush Is Raising Voyager Therapeutics (VYGR) FY17 Rev. Estimate To 10.3 M From 4.7 M
11/3/2017 2:25:17 PM Wedbush Is Raising Voyager Therapeutics (VYGR) Q4 17 Rev. Estimate To 6.5 M From 1.1 M
11/3/2017 2:24:04 PM Wedbush Is Cutting Voyager Therapeutics (VYGR) FY18 Estimate To -3.80 From -2.84
11/3/2017 2:23:43 PM Wedbush Is Lowering Voyager Therapeutics (VYGR) Q4 18 Estimate To -0.97 From -0.67
11/3/2017 2:23:27 PM Wedbush Is Cutting Voyager Therapeutics (VYGR) Q3 18 Estimate To -0.96 From -0.65
11/3/2017 2:23:10 PM Wedbush Is Lowering Voyager Therapeutics (VYGR) Q2 18 Estimate To -0.94 From -0.77
11/3/2017 2:20:31 PM Wedbush Is Cutting Voyager Therapeutics (VYGR) Q1 18 Estimate To -0.93 From -0.76
11/3/2017 2:17:12 PM Wedbush Is Cutting Voyager Therapeutics (VYGR) FY17 Estimate To -3.03 From -2.95
11/3/2017 2:16:14 PM Wedbush Is Increasing Voyager Therapeutics (VYGR) Q4 17 Estimate To -0.76 From -0.82
10/31/2017 8:44:54 AM Wedbush Is Raising Voyager Therapeutics (VYGR) 2017 Estimate To -2.95 From -3.01
10/17/2017 3:02:12 AM Voyager Therapeutics Announces New Data Presentations At The Congress Of The European Society Of Gene And Cell Therapy